financetom
Business
financetom
/
Business
/
Nike posts surprise quarterly revenue drop on choppy demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nike posts surprise quarterly revenue drop on choppy demand
Jun 27, 2024 1:50 PM

(Reuters) -Nike ( NKE ) reported a surprise drop in fourth-quarter revenue on Thursday, as the sportswear maker struggled with low demand for its apparel and footwear amid rising competition from brands such as On and Hoka.

Shares of the company fell 4.6% in extended trade.

Even though Nike ( NKE ) has outlined a plan to streamline its portfolio, analysts note that it would be some time before the sportswear company can revive demand as innovation and launches of new product lines take time.

Nike's ( NKE ) efforts to drive more sales through its direct-to-consumer channel have also taken a hit as customers turn more picky about their non-essential spending and look to spend their dollars on more fashionable and innovative brands such as On and Deckers' Hoka.

Nike ( NKE ) is also losing ground to rival Adidas' retro-style Gazelle and Samba sneakers, which have helped the European sportswear maker see a rebound in demand after its damaging break-up with rapper Ye.

The Air Jordan maker is also doubling down on wholesale partnerships after years of pulling back on distribution. Nike ( NKE ) executives in March acknowledged that their direct-to-consumer push was not driving growth and had instead led to a drop in its market share.

Fourth-quarter gross margin increased 110 basis points to 44.7%, primarily due to Nike's ( NKE ) plan to cut costs through layoffs and reduced supply of some of its underperforming products as well as lower ocean freight rates and logistics costs.

Nike's ( NKE ) net revenue fell 1.71% to $12.61 billion, compared with analysts' average estimate of a 0.13% rise to $12.84 billion, per LSEG data.

The company's net income for the reported quarter rose 45% to $1.50 billion, or 99 cents per share, compared with $1.03 billion a year earlier.

(Reporting by Juveria Tabassum and Ananya Mariam Rajesh in Bengaluru; Editing by Shinjini Ganguli)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
KKR Completes Acquisition of OSTTRA From S&P Global and CME Group
KKR Completes Acquisition of OSTTRA From S&P Global and CME Group
Oct 10, 2025
NEW YORK--(BUSINESS WIRE)-- KKR, a leading global investment firm, today announced that investment funds managed by KKR have completed the acquisition of OSTTRA, a leading provider of post-trade solutions for the global OTC market, from S&P Global and CME Group. The terms of the deal for OSTTRA equaled total enterprise value at $3.1 billion. Established in 2021 as a joint...
S&P Global and CME Group Complete Sale of OSTTRA to KKR
S&P Global and CME Group Complete Sale of OSTTRA to KKR
Oct 10, 2025
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- S&P Global ( SPGI ) and CME Group today announced that they have completed the sale of OSTTRA to KKR, a leading global investment firm. The terms of the deal for OSTTRA equaled total enterprise value at $3.1 billion, which will be divided evenly between S&P Global ( SPGI ) and CME Group...
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
Oct 10, 2025
Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseases Transaction further strengthens BMS’s industry-leading cell therapy portfolio, expanding CAR T-cell access to more patients in the future PRINCETON, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Bristol Myers Squibb ( BMY ) and Orbital Therapeutics (“Orbital”) today announced a...
Serve Robotics Announces $100 Million Registered Direct Offering of Common Stock
Serve Robotics Announces $100 Million Registered Direct Offering of Common Stock
Oct 10, 2025
SAN FRANCISCO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Serve Robotics Inc. ( SERV ) (Serve or the Company) , a leading autonomous sidewalk delivery company, announced today that the Company has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 6,250,000 shares of common stock, pursuant to a registered direct offering, expected to result...
Copyright 2023-2026 - www.financetom.com All Rights Reserved